Opus Genetics, Inc. 8-K

What Happened
Opus Genetics, Inc. (IRD) filed an Item 7.01 Regulation FD disclosure on Jan 12, 2026, announcing that company management will deliver a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026 at 8:15 a.m. Pacific Time. The presentation slides are attached to the filing as Exhibit 99.1 and have been posted on the company’s investor relations website.

Key Details

• Presentation date/time: January 15, 2026 at 8:15 a.m. Pacific Time.
• Format: Live presentation with a webcast accessible via Opus Genetics’ investor relations site (https://ir.opusgtx.com).
• Filing: Presentation included as Exhibit 99.1 to the Form 8-K (Regulation FD disclosure).
• Slides also made available in the “Overview” section of the company’s IR website.

Why It Matters
This filing publicly notifies investors that Opus Genetics’ management will present at a major industry conference and makes the presentation materials broadly available under Regulation FD, ensuring equal access to the information. Investors who want the company’s latest strategic or program updates can view the live webcast or review the posted slides; the 8-K does not include new financial results or other material changes beyond the presentation disclosure.